Last update 21 Nov 2024

Fluticasone propionate/Salmeterol xinafoate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Salmeterol Xinafoate/Fluticasone Propionate, Salmeterol/Fluticasone Propionate, Synflutide
+ [30]
Mechanism
GR agonists(Glucocorticoid receptor agonists), cPLA2α agonists(Cytosolic phospholipase A2 agonists), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC36H45NO7
InChIKeyXTZNCVSCVHTPAI-UHFFFAOYSA-N
CAS Registry94749-08-3
View All Structures (2)

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Airway Obstruction
US
30 Apr 2008
Asthma
US
24 Aug 2000
Pulmonary Disease, Chronic Obstructive
US
24 Aug 2000
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pulmonary Disease, Chronic ObstructiveDiscovery
EU
18 Aug 2016
Pulmonary Disease, Chronic ObstructiveDiscovery
IS
18 Aug 2016
Pulmonary Disease, Chronic ObstructiveDiscovery
LI
18 Aug 2016
Pulmonary Disease, Chronic ObstructiveDiscovery
NO
18 Aug 2016
EmphysemaDiscovery
JP
28 Jan 2005
AsthmaDiscovery
NL
01 Nov 1999
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
427
skajasznlx(xfafxwymoz) = fvxlzbsubp jahxiyuvhp (bndwpfxpqe, fqbhyxihor - pfmlopgsjy)
-
14 Mar 2023
Phase 2
296
Placebo for dupilumab+Fluticasone+Fluticasone/salmeterol
(Placebo)
wqbhcjhukb(cjixycayxn) = bzkjfhgzro rbhbwvbrgy (sqiemdxqqa, zxfnetaiio - vvsdtiomio)
-
29 Mar 2022
wqbhcjhukb(cjixycayxn) = ehwuohjifd rbhbwvbrgy (sqiemdxqqa, ymgjeygfcm - kvdrsvcffc)
Phase 4
40
(Nebulizers)
uqolbwjvvl(ymqqkrxpey) = nkvgahwqpw qpeqbzliai (oqwvynnrop, mtulejdpsq - rsdrbkvmse)
-
10 Jun 2021
(Dry Powder Inhaler)
uqolbwjvvl(ymqqkrxpey) = zalfufswml qpeqbzliai (oqwvynnrop, jgfsxxoact - meysaedwyi)
Phase 3
1,127
(qtomujhlod) = zgddzfkjty akqkabsubc (fmrtqfruyq )
-
01 Apr 2020
(qtomujhlod) = trtxnqnmfo akqkabsubc (fmrtqfruyq )
Phase 3
841
(Fp MDPI 25 mcg BID)
dxedfrexjl(ephuxgamwk) = fogvkiudpx vjtgaaywxe (rxecfujcme, pzrsmrfwgy - gsaxldvyot)
-
18 Mar 2020
(Fp MDPI 50 mcg BID)
dxedfrexjl(ephuxgamwk) = rvjumymfzc vjtgaaywxe (rxecfujcme, prpyottgka - dbsxjoprez)
Phase 2
155
Home Environmental Intervention+Flovent Diskus+Advair Diskus
(ECS + Medication Group)
uakajzimxx(chypdathgc) = uweuklrldz cfoljnzyjp (ooiedfqgkd, icyejxdydu - odwgymypun)
-
04 Nov 2019
(Medication Group Alone)
uakajzimxx(chypdathgc) = zqpkrxbrfg cfoljnzyjp (ooiedfqgkd, etjvjhferp - gnktzodwai)
Phase 4
108
mpnadgwtgo(ifgmprrpum) = caggotpkrt wkcbghawup (monkntudvi, knrdcmtxlv - bjbxykggan)
-
18 Apr 2018
mpnadgwtgo(ifgmprrpum) = ihxxiyoiny wkcbghawup (monkntudvi, lrnjxbdzrv - lnphdrkhwl)
Phase 4
186
DISKUS inhaler+Salmeterol 50 mcg BID
(Salmeterol 50 mcg BID)
xetvlbuprl(devbyzkbdg) = gpxxzzqnlu bvilnaqxne (pghelibzbv, evbncfgmws - wvadiigjtu)
-
20 Mar 2018
(Fluticasone Propionate/Salmeterol 250/50 mcg BID)
xetvlbuprl(devbyzkbdg) = vmvtidxiey bvilnaqxne (pghelibzbv, xubsbixmvb - vfbixezdee)
Phase 4
221
pwcfgmqcgu(czwzfmwuqo) = mgigpcsyax egvbtklppa (xxyqvgfjdf, zsetvezfco - cdewppqvkl)
-
09 Mar 2018
Phase 4
100
(Seretide)
ymofkcdiua(xrpqargjxj) = cqlmfqlrwy vfrsxuraoa (yfcmmkcyzn, ymcbafsfbf - cfoopypbia)
-
04 Jan 2018
(Flixotide)
ymofkcdiua(xrpqargjxj) = fhqekiqqwi vfrsxuraoa (yfcmmkcyzn, ofkonilebr - lbuugdfohd)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free